Scott Andrew Smith Bio Atla, Inc. (BCAB) insider trading activity

Scott Andrew Smith is of BioAtla, Inc.. Currently has a direct ownership of 298,050 shares of BCAB, which is worth approximately $512,646. The most recent transaction as insider was on Aug 31, 2024, when has been sold 2,181 shares (Common Stock) at a price of $1.77 per share, resulting in proceeds of $3,860. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 298K

0.73% 3M change

1.5% 12M change

Total Value Held $512,646

Scott Andrew Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 31 2024	SELL Payment of exercise price or tax liability	$3,860 $1.77 p/Share	2,181 Reduced 0.73%	298,050 Common Stock
Jul 31 2024	SELL Payment of exercise price or tax liability	$3,947 $1.81 p/Share	2,181 Reduced 0.72%	300,231 Common Stock
Jun 30 2024	SELL Payment of exercise price or tax liability	$2,987 $1.37 p/Share	2,181 Reduced 0.72%	302,412 Common Stock
Jun 13 2024	BUY Grant, award, or other acquisition	-	16,500 Added 5.14%	304,593 Common Stock
May 31 2024	SELL Payment of exercise price or tax liability	$3,293 $1.51 p/Share	2,181 Reduced 0.75%	288,093 Common Stock
Apr 30 2024	SELL Payment of exercise price or tax liability	$4,929 $2.26 p/Share	2,181 Reduced 0.75%	290,274 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$7,502 $3.44 p/Share	2,181 Reduced 0.74%	292,455 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$5,888 $2.7 p/Share	2,181 Reduced 0.73%	294,636 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$4,187 $1.92 p/Share	2,181 Reduced 0.73%	296,817 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$4,405 $2.46 p/Share	1,791 Reduced 0.6%	298,998 Common Stock
Nov 30 2023	SELL Payment of exercise price or tax liability	$3,170 $1.77 p/Share	1,791 Reduced 0.59%	300,789 Common Stock
Oct 31 2023	SELL Payment of exercise price or tax liability	$2,632 $1.47 p/Share	1,791 Reduced 0.59%	302,580 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$3,044 $1.7 p/Share	1,791 Reduced 0.58%	304,371 Common Stock
Aug 31 2023	SELL Payment of exercise price or tax liability	$4,495 $2.51 p/Share	1,791 Reduced 0.58%	306,162 Common Stock
Jul 31 2023	SELL Payment of exercise price or tax liability	$5,355 $2.99 p/Share	1,791 Reduced 0.58%	307,953 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$5,373 $3.0 p/Share	1,791 Reduced 0.57%	309,744 Common Stock
May 31 2023	SELL Payment of exercise price or tax liability	$5,641 $3.15 p/Share	1,791 Reduced 0.57%	311,535 Common Stock
Apr 30 2023	SELL Payment of exercise price or tax liability	$6,035 $3.37 p/Share	1,791 Reduced 0.57%	313,326 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$4,799 $2.68 p/Share	1,791 Reduced 0.57%	315,117 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$5,337 $2.98 p/Share	1,791 Reduced 0.56%	316,908 Common Stock
Jan 31 2023	SELL Payment of exercise price or tax liability	$8,265 $3.79 p/Share	2,181 Reduced 0.68%	318,699 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$14,775 $8.25 p/Share	1,791 Reduced 0.56%	320,880 Common Stock
Nov 30 2022	SELL Payment of exercise price or tax liability	$19,718 $11.01 p/Share	1,791 Reduced 0.55%	322,671 Common Stock
Oct 31 2022	SELL Payment of exercise price or tax liability	$12,339 $6.89 p/Share	1,791 Reduced 0.55%	324,462 Common Stock
Sep 30 2022	SELL Payment of exercise price or tax liability	$13,791 $7.7 p/Share	1,791 Reduced 0.55%	326,253 Common Stock

Also insider at

VTRS

Viatris Inc Healthcare

Chief Executive Officer

BCAC

Brookline Capital Acquisition Corp. Financial Services

Director

SAS